MADEDDU, GIORDANO
 Distribuzione geografica
Continente #
NA - Nord America 541
AS - Asia 407
EU - Europa 407
SA - Sud America 89
AF - Africa 51
OC - Oceania 1
Totale 1.496
Nazione #
US - Stati Uniti d'America 516
RU - Federazione Russa 251
SG - Singapore 191
IT - Italia 72
CN - Cina 70
BR - Brasile 68
VN - Vietnam 63
KR - Corea 32
FR - Francia 26
CI - Costa d'Avorio 21
NG - Nigeria 18
CA - Canada 13
HK - Hong Kong 12
IN - India 12
GB - Regno Unito 8
MX - Messico 8
AR - Argentina 7
ES - Italia 7
JP - Giappone 7
DE - Germania 6
PL - Polonia 6
FI - Finlandia 5
IQ - Iraq 5
NL - Olanda 5
BD - Bangladesh 4
VE - Venezuela 4
ZA - Sudafrica 4
CL - Cile 3
CO - Colombia 3
ID - Indonesia 3
SE - Svezia 3
UA - Ucraina 3
BG - Bulgaria 2
EC - Ecuador 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
KE - Kenya 2
SN - Senegal 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BJ - Benin 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 1.496
Città #
Dallas 150
Moscow 131
Singapore 128
Santa Clara 90
Ashburn 48
San Jose 43
Los Angeles 35
Seoul 32
Beijing 22
Abidjan 21
Lauterbourg 21
Ho Chi Minh City 20
Hefei 17
Abuja 15
New York 14
Hong Kong 12
Rende 12
São Paulo 12
Buffalo 10
Catania 10
Council Bluffs 10
Hanoi 10
Rome 8
Tokyo 7
Montreal 6
Orem 6
Bologna 5
Boston 5
Brooklyn 5
Mexico City 5
Warsaw 5
Chennai 4
Denver 4
Johannesburg 4
Kochi 4
Lappeenranta 4
Misterbianco 4
Atlanta 3
Bastiglia 3
Chicago 3
Houston 3
London 3
Paris 3
Phoenix 3
Porto Alegre 3
Salvador 3
San Francisco 3
Santiago 3
Stockholm 3
Toronto 3
Amsterdam 2
Bandung 2
Boardman 2
Bắc Giang 2
Caruaru 2
Da Nang 2
Dublin 2
Guangzhou 2
Gütersloh 2
Haiphong 2
Ipirá 2
Kyiv 2
Madrid 2
Manchester 2
Messina 2
Milan 2
Nairobi 2
Norfolk 2
Nova Friburgo 2
Palermo 2
Port Harcourt 2
Quảng Ngãi 2
San Giovanni la Punta 2
Siena 2
Tashkent 2
Thái Nguyên 2
Turin 2
Almirante Brown 1
Amman 1
Anápolis 1
Arcoverde 1
Aswān 1
Baghdad 1
Belo Campo 1
Belo Horizonte 1
Bexley 1
Bismarck 1
Boca Raton 1
Bogotá 1
Bratislava 1
Budapest 1
Buenos Aires 1
Bắc Ninh 1
Cachoeiras de Macacu 1
Calgary 1
Can Tho 1
Canoas 1
Castanhal 1
Caxias do Sul 1
Citrus Heights 1
Totale 1.055
Nome #
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 139
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 93
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results a large multicentre observational prospective cohort (SCOLTA) 86
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 83
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 82
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 73
Factors associated with weight gain in people treated with dolutegravir 65
Weight gain: A possible side effect of all antiretrovirals 63
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 63
Enhanced immunological recovery with early start of antiretroviral therapy during acute or early HIV infection–results of Italian network of acute HIV infection (Inaction) retrospective study 61
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 59
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 59
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 54
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 53
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 52
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 51
Efficacy of 1998 Vs 2006 first-line antiretroviral regimens for HIV infection: An ordinary clinics retrospective investigation 51
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 49
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project) 48
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 48
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 47
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: Results of a nationwide cross-sectional study 42
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 39
Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort 36
Efficacy and Safety of Cabotegravir–Rilpivirine in PLWH: A Real-World Study 26
Totale 1.522
Categoria #
all - tutte 4.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 0 0 0 0 0 0 0 0 3 0 0 0
2023/20242 0 0 0 0 0 1 0 0 0 0 0 1
2024/2025346 8 7 7 7 93 49 3 12 34 41 33 52
2025/20261.171 59 56 190 98 195 276 107 40 62 88 0 0
Totale 1.522